Upper Limb · 4 min read
Trigger Finger: Simple Condition, Important Decisions
Trigger finger is among the most common conditions in hand surgery — and among those most frequently mismanaged through either over-treatment or under-treatment. The decision tree for stenosing tenosynovitis is straightforward when the evidence is understood clearly, and the outcomes at every stage of management, when correctly applied, are excellent.
Stenosing tenosynovitis — trigger finger — occurs when inflammation and thickening of the flexor tendon sheath at the A1 pulley level creates a size mismatch between the tendon and its fibro-osseous tunnel. The result is the characteristic catching, locking, or triggering of the digit in flexion, with or without pain at the base of the finger. The condition is more prevalent in diabetic patients, those with rheumatoid arthritis, and — without obvious predisposing systemic condition — disproportionately affects women in middle age. Understanding these associations is clinically relevant: a new trigger finger in a patient without known diabetes is a prompt for fasting glucose assessment.
The evidence-based treatment ladder
Splinting — immobilising the MCP joint in extension while allowing IP joint motion — produces resolution in a meaningful proportion of mild to moderate cases at 6 weeks, particularly in patients with shorter symptom duration. Its advantage is complete absence of risk; its limitation is compliance and the higher recurrence rate compared to injection.
Corticosteroid injection at the A1 pulley — the most widely used first-line intervention — produces resolution rates of 50–70% at 3 months in non-diabetic patients, with a meaningful proportion requiring a second injection for sustained effect. Diabetic patients have lower response rates and shorter durations of benefit, and the transient hyperglycaemic effect of peritendinous corticosteroid deserves explicit acknowledgement in the consent conversation. Ultrasound-guided injection improves accuracy of delivery and — in published series — improves outcome rates compared to landmark-guided injection.
Surgical release: reliable and definitive
Open or percutaneous A1 pulley release produces resolution rates exceeding 95% with a very low complication profile in experienced hands. It is the appropriate choice for patients who have failed two corticosteroid injections, for those with a locked trigger that will not reduce passively, and for patients who prefer a single definitive treatment over repeat injections. Percutaneous release under local anaesthesia — dividing the A1 pulley with a needle tip under direct palpation — produces outcomes equivalent to open release in the thumb and long fingers, with the significant advantages of reduced recovery time and avoidance of formal surgical incision.
Trigger finger managed well — with the right intervention at the right stage — is one of the most satisfying conditions in hand surgery. Every stage of the treatment ladder works when applied correctly and at the appropriate time.
The exception: trigger finger in children — paediatric trigger thumb in particular — behaves differently from the adult condition and warrants specific consideration. Surgical release is generally the preferred management in persistent paediatric cases, as the condition does not resolve reliably with injection in this age group.
💬 Do you use ultrasound guidance for trigger finger injections routinely — and has it changed your outcome rates compared to landmark-guided technique?